Key Stories Impacting Johnson & JohnsonHere are the key news stories impacting Johnson & Johnson this week:Get Johnson & Johnson alerts:Positive Sentiment: The FDA cleared J&J’s OTTAVA robotic-assisted surgery system, marking the company’s entry into surgical robotics. Three Strong Buy Dividend Aristocrat StocksJ&J was highlighted as a “Strong Buy” Dividend Aristocrat for dependable income. Johnson & Johnson (NYSE:JNJ – Get Free Report) last posted its earnings results on Wednesday, July 15th. As a group, equities research analysts predict that Johnson & Johnson will post 11.69 earnings per share for the current fiscal year. Featured ArticlesReceive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.